Ping Li

11.8k total citations · 2 hit papers
334 papers, 8.3k citations indexed

About

Ping Li is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Ping Li has authored 334 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 72 papers in Nephrology and 58 papers in Epidemiology. Recurrent topics in Ping Li's work include Chronic Kidney Disease and Diabetes (41 papers), Renal Diseases and Glomerulopathies (30 papers) and Liver Disease Diagnosis and Treatment (22 papers). Ping Li is often cited by papers focused on Chronic Kidney Disease and Diabetes (41 papers), Renal Diseases and Glomerulopathies (30 papers) and Liver Disease Diagnosis and Treatment (22 papers). Ping Li collaborates with scholars based in China, United States and Canada. Ping Li's co-authors include Jack V. Tu, Cynthia A. Jackevicius, Liyin Zhu, Elaine Y. Lin, William J. Muller, Kathleen D. Whitney, Jeffrey W. Pollard, Joan G. Jones, Hui Y. Lan and Donald A. Redelmeier and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Ping Li

311 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

2003 830 citations Ping Li et al. profile →
Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2

2003 647 citations Ping Li, Richard J. Johnson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ping Li China	42	2.5k	1.6k	1.4k	1.1k	796	334	8.3k
Aihua Zhang China	51	3.9k 1.5×	1.8k 1.2×	862 0.6×	804 0.7×	409 0.5×	313	8.4k
Chul Woo Yang South Korea	47	2.0k 0.8×	3.0k 1.9×	1.1k 0.8×	2.2k 2.1×	716 0.9×	526	9.8k
Sydney Tang Hong Kong	51	2.0k 0.8×	4.3k 2.7×	974 0.7×	1.1k 1.0×	460 0.6×	314	9.4k
Ping Fu China	38	1.5k 0.6×	1.8k 1.2×	606 0.4×	782 0.7×	258 0.3×	240	5.1k
Myron D. Gross United States	52	1.7k 0.7×	470 0.3×	1.3k 0.9×	661 0.6×	520 0.7×	187	8.6k
Shin‐Wook Kang South Korea	55	2.2k 0.9×	6.1k 3.9×	1.3k 0.9×	1.7k 1.5×	747 0.9×	530	12.4k
Vishal S. Vaidya United States	48	2.1k 0.8×	3.9k 2.5×	683 0.5×	1.1k 1.0×	444 0.6×	104	8.8k
Hiroshi Watanabe Japan	52	4.4k 1.7×	1.1k 0.7×	981 0.7×	1.2k 1.1×	1.6k 2.0×	548	12.4k
Jacek Rysz Poland	52	1.9k 0.8×	1.3k 0.8×	1.2k 0.8×	2.8k 2.5×	382 0.5×	360	10.3k
Erik Ingelsson Sweden	63	2.9k 1.2×	1.0k 0.7×	2.1k 1.5×	1.5k 1.4×	481 0.6×	209	12.8k

Countries citing papers authored by Ping Li

Since Specialization

Citations

This map shows the geographic impact of Ping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Li more than expected).

Fields of papers citing papers by Ping Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Li. The network helps show where Ping Li may publish in the future.

Co-authorship network of co-authors of Ping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Li. A scholar is included among the top collaborators of Ping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Li. Ping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miao, Hua, et al.. (2025). Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design Development and Therapy. Volume 19. 9457–9480.

Miao, Hua, Shui-juan Zhang, Xinyu Wu, Ping Li, & Ying‐Yong Zhao. (2025). Tryptophan metabolism as a target in gut microbiota, ageing and kidney disease. International Journal of Biological Sciences. 21(10). 4374–4387. 12 indexed citations

Li, Limei, Jun Zhao, Haishan Zhang, et al.. (2024). Silencing ANLN hinders the proliferation, migration, invasion, and angiogenesis of oral squamous cell carcinoma. Pathology - Research and Practice. 262. 155563–155563. 1 indexed citations

Wang, Ying, Tongtong Liu, Weijing Liu, Hailing Zhao, & Ping Li. (2024). Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023. Frontiers in Pharmacology. 15. 1401939–1401939. 4 indexed citations

Wu, Ziyan, Yang Zhao, Chaojun Hu, et al.. (2024). Antineutrophil cytoplasmic antibody is an independent risk factor in rheumatoid arthritis-associated interstitial lung disease. Clinica Chimica Acta. 561. 119845–119845. 2 indexed citations

Li, Ping, Fuzai Yin, Yali Liu, et al.. (2023). Total sugar intake is associated with higher prevalence of depressive symptoms in obese adults. Frontiers in Public Health. 10. 1069162–1069162. 7 indexed citations

Wang, Jingjing, Rui Zhang, Hailing Zhao, et al.. (2023). Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy. Frontiers in Pharmacology. 14. 1207777–1207777. 13 indexed citations

Chen, Ming, et al.. (2023). Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB/TNF-a/SREBP1c signaling pathway. Chemico-Biological Interactions. 385. 110711–110711. 18 indexed citations

Jiang, Man, et al.. (2023). Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis. British Journal of Pharmacology. 180(23). 3008–3023. 11 indexed citations

10.

Wang, Yi, et al.. (2023). Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis. European journal of medical research. 28(1). 525–525. 6 indexed citations

11.

Liang, Bing, Le Shi, Hua Li, et al.. (2023). Hydrogen-Rich Water Ameliorates Metabolic Disorder via Modifying Gut Microbiota in Impaired Fasting Glucose Patients: A Randomized Controlled Study. Antioxidants. 12(6). 1245–1245. 12 indexed citations

12.

Zhou, Weie, Xuefeng Zhou, Yuan Zhang, et al.. (2021). A Network Pharmacology-Based Approach for Exploring Key Active Compounds and Pharmacological Mechanisms of Tangshen Formula for Treatment of Diabetic Nephropathy. Journal of Diabetes Research. 2021. 1–17. 3 indexed citations

13.

Liu, Tong‐Tong, Fang Ma, Huimin Mao, et al.. (2020). A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease. Journal of Diabetes Research. 2020. 1–14. 19 indexed citations

14.

Ma, Liang, Hailing Zhao, Tingting Zhao, et al.. (2020). Association of Epoxide Hydrolase 2 Gene Arg287Gln with the Risk for Primary Hypertension in Chinese. International Journal of Hypertension. 2020. 1–7. 8 indexed citations

15.

Ma, Liang, Meihua Yan, Xiaomu Kong, et al.. (2018). Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients. Journal of Diabetes Research. 2018. 1–6. 10 indexed citations

16.

Yin, Tingting, Yan Bi, Ping Li, et al.. (2018). Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial. Nutrition & Metabolism. 15(1). 67–67. 16 indexed citations

17.

Huang, Min, Qionglin Liang, Ping Li, et al.. (2013). Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system. Molecular BioSystems. 9(8). 2134–2141. 27 indexed citations

18.

Karkouti, Keyvan, Thérèse A. Stukel, W. Scott Beattie, et al.. (2012). Relationship of Erythrocyte Transfusion with Short- and Long-term Mortality in a Population-based Surgical Cohort. Anesthesiology. 117(6). 1175–1183. 30 indexed citations

19.

Li, Zhiping, Xiaomei Chen, Xiaojing Liu, et al.. (2008). [Correlation study of physical and biologic parameters to acute radiation pneumonitis].. PubMed. 39(5). 796–800. 1 indexed citations

20.

Li, Quan‐Zhen, Ping Li, Gabriela García, Richard J. Johnson, & Lili Feng. (2005). Genomic Profiling of Neutrophil Transcripts in Asian Qigong Practitioners: A Pilot Study in Gene Regulation by Mind–Body Interaction. The Journal of Alternative and Complementary Medicine. 11(1). 29–39. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact